Biotech Stocks Investors Are Taking Notice Of

With many clinical and regulatory catalysts on the way, the rally we are seeing throughout the biotech sector should gain even more momentum. Last week, every single fund tracking the sector had recorded new highs, and analysts believe that this sentiment could endure for the remainder of the year.

 

biotechstockstowatch.jpg

 

Both the iShares NASDAQ Biotechnology Index (IBB) and the S&P Biotech ETF (XBI) are up around 20%, the Health Care SPDR ETF (XLV) has gained about 17%, while the S&P Pharmaceuticals ETF (XPH) has seen gains of 29% and closed just a penny shy of all-time highs on Friday.

With several biotech companies anticipated to announced news this month, this should add even more steam to the rally we are seeing throughout the sector. Here is a more in depth look at what investors should be watching out for this month.

 

Click Here For 3 Biotech Stocks Investors Are Taking Notice Of This Month

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s